Democrats’ effort to cap insulin prices faces Republican opposition
WASHINGTON – Democrats promise they’ll soon fix a problem that has tormented diabetics for years – the soaring price of [...]
Drug price controls are essential for small businesses
As small businesses across the country buckle up for another possible winter of COVID-19, they suffered an avoidable blow in [...]
The price of curing cancer
- Research - Open Access - [Published:] The price of curing cancer 1328 (2021) [Cite this article](#citeas) 8 Accesses - [...]
Manager, Value & Evidence Strategy (Remote) | HealthEconomics
Are you looking to make a difference in a patient’s life? At AmerisourceBergen, you will find an innovative and collaborative [...]
S1_E12: Dr. Shrividya Iyer, Executive Director, Oncology Global Real World Evidence (RWE) & US HEOR, Eisai
Dr. Shrividya Iyer is a health care researcher currently working on cancer health outcomes research, with a key focus on [...]
Survey, Whitepaper from PrognosⓇ Health and Reuters Events™ Uncovers RWD Trends in the Pharmaceutical Industry
NEW YORK--(BUSINESS WIRE)--Dec 9, 2021-- Prognos Health recently partnered with ReutersEvents to survey brand, commercial strategy, and data science leaders [...]
Leading Pharma Company Brings Products to Market Faster with Datatron’s MLOps and AI Governance Solution
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px [...]
Focussing on pharma’s blind spot
Industry’s free pass to its target audience has been shredded by the pandemic leaving the sales force compass struggling to [...]
Frontiers Health Digital Innovators: Aptar’s Sai Shankar
Continuing his Frontiers Health Digital Innovator’s series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. [...]
Post-Brexit medicines regulation must have international scope
Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left [...]
Mind the gap: Are you delivering what HCPs value or what you want them to have?
Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of [...]
Deep Dive: Digital Health 2021
There is no doubt that the COVID-19 pandemic has accelerated the adopt of digital health. As this issue’s contributors discuss, [...]
Creating an effective patient engagement set of practices that is enduring and future-proof
For the past ten years we’ve seen a steady acceptance of the need for patient engagement practises to become routine [...]
Regulation optimisation could save thousands of life years
Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across the European [...]
Leveraging augmented analytics to drive better business decisions
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was [...]
Drug development and working with specialised Rare Disease networks
There are currently an estimated 300 million people living with one or more Rare Diseases across the world. There are [...]
2021 in review: Building the framework of a patient-centric industry
Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not [...]
ObvioHealth Discusses the Rise of Real-World Data Within Clinical Trials
ObvioHealth brings attention to the current rise of real-world data and real-world evidence usage within clinical trials — — Real-world [...]
Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market
Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market Third Add-on Acquisition Under Behrman's Ownership Expands European Presence in [...]
EVERSANA Announces Real-World Data Agreement with Janssen to Augment Development of Chronic Disease Care Therapies
CHICAGO EVERSANA , the pioneer of next generation services to the global life sciences industry, today announced an agreement with [...]
Health tech industry learns true value of medical data
Writer is the co-founder and head of research and development for Qure.ai, an AI developer for medical imaging. In the [...]
OptimizeRx’s Evidence-Based Physician Engagement Solution
OptimizeRx’s Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360 The solution uses [...]
Global Real-World Evidence Solutions Market Analysis, Application & Forecast to 2021-2028
Bharat Book Bureau Provides the Trending Market Research Report on “ Real-World Evidence (RWE) Solutions Market by Component, Application, End [...]
OptimizeRx’s Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360
ROCHESTER, Mich., Dec. 29, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”)(Nasdaq: OPRX), a leading provider of point-of-care technology [...]
Matt Michelson, President of Genesis AI at Genesis Research – Interview Series
Matt Michelson, is the President of Genesis AI at Genesis Research , an international HEOR and Real-World Evidence research organization [...]